RELIEF THERAPEUTICS HOLDING AG CHF4.00 (REGD)

The current price of 0QKQ is 1.300 CHF — it has increased by 6.12% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange RELIEF THERAPEUTICS HOLDING AG CHF4.00 (REGD) stocks are traded under the ticker 0QKQ.

0QKQ stock is 5.93% volatile and has beta coefficient of 0.85. Check out the list of the most volatile stocks — is RELIEF THERAPEUTICS HOLDING AG CHF4.00 (REGD) there?

Yes, you can track RELIEF THERAPEUTICS HOLDING AG CHF4.00 (REGD) financials in yearly and quarterly reports right on TradingView.

Today RELIEF THERAPEUTICS HOLDING AG CHF4.00 (REGD) has the market capitalization of ‪13.88 M‬, it has increased by 6.40% over the last week.

No, 0QKQ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, 0QKQ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RELIEF THERAPEUTICS HOLDING AG CHF4.00 (REGD) stock right from TradingView charts — choose your broker and connect to your account.

0QKQ reached its all-time high on Aug 10, 2020 with the price of 275.565 CHF, and its all-time low was 0.400 CHF and was reached on Dec 23, 2019.
See other stocks reaching their highest and lowest prices.

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So RELIEF THERAPEUTICS HOLDING AG CHF4.00 (REGD) technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating RELIEF THERAPEUTICS HOLDING AG CHF4.00 (REGD) stock shows the sell signal. See more of RELIEF THERAPEUTICS HOLDING AG CHF4.00 (REGD) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.